Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1).
公开了式(1)的ERK抑制剂及其药学上可接受的盐。同时公开了使用式(1)的化合物治疗癌症的方法。
Compounds that are ERK inhibitors
申请人:Merck Sharp & Dohme Corp.
公开号:US09233979B2
公开(公告)日:2016-01-12
Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1).